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Abstract
Background: Nelson Bay orthoreovirus (NBV) is a fusogenic bat borne virus with an unknown zoonotic potential.
Previous studies have shown that NBV can infect and replicate in a wide variety of cell types derived from their
natural host (bat), as well as from human, mouse and monkey. Within permissive cells, NBV induced significant
cytopathic effects characterised by cell-cell fusion and syncytia formation. To understand the molecular events
that underpin NBV infection we examined the host transcriptome and proteome response of two cell types,
derived from bat (PaKiT03) and mouse (L929), to characterise differential cellular susceptibility to NBV.
Results: Despite significant differences in NBV replication and cytopathic effects in the L929 and PaKiT03 cells, the host
response was remarkably similar in these cells. At both the transcriptome and proteome level, the host response was
dominated by IFN production and signalling pathways. The majority of proteins up-regulated in L929 and PaKiT03 cells
were also up-regulated at the mRNA (gene) level, and included many important IFN stimulated genes. Further
functional experimentation demonstrated that stimulating IFN signalling prior to infection, significantly reduced NBV
replication in PaKiT03 cells. Moreover, inhibiting IFN signalling (through specific siRNAs) increased NBV replication in
L929 cells. In line with the significant cytopathic effects seen in PaKiT03 cells, we also observed a down-regulation of
genes involved in cell-cell junctions, which may be related to the fusogenic effects of NBV.
Conclusions: This study provides new multi-dimensional insights into the host response of mammalian cells to NBV
infection. We show that IFN activity is capable of reducing NBV replication, although it is unlikely that this is solely
responsible for the reduced replication of NBV in L929 cells. The molecular events that underpin the fusogenic cytopathic
effects described here will prove valuable for identifying potential therapeutic targets against fusogenic orthoreovirus.
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Background
Nelson Bay orthoreovirus (NBV) is the prototypic mem-
ber of the Pteropine orthoreovirus species. This group
contains viruses that have been isolated from both bats
and humans. NBV was isolated in 1970 from the blood of
a grey-headed flying fox (Pteropus poliocephalus) [1]. Bats
are considered natural hosts for a number of Pteropine
orthoreovirus species, including NBV, Pulau virus [2] and
Xi River virus [3]. Human isolates of Pteropine orthoreo-
virus species are genetically related to NBV [4] and are
often from patients with respiratory illness. Indeed,
Melaka virus (MelV) was the first bat-related orthoreo-
virus isolated from a human exhibiting respiratory
symptoms [5] with the transmission believed to be from
bats. Further, other Pteropine orthoreovirus species such
as Kampar, HK23629/07, HK46886/09, HK50842/10 and
Miyazaki-Bali/2007 have all been isolated from humans
presenting respiratory illness [6–9]. A link to either direct
or indirect contact with bats was demonstrated in a num-
ber of these cases [5, 6, 8, 10]. A seroprevalence study of
272 human serum samples in Vietnam identified 12 serum
samples to be seropositive for Pteropine orthoreovirus.
This suggests that human infection with Pteropine orthor-
eovirus species is potentially more prevalent than initially
thought [11]. To date, NBV has not been linked to clinical
disease in humans, however given the increasing number
of spill-over events from bats to humans, the potential
transmission – and pathogenicity – of this virus in humans,
domestic animals and livestock must be considered.
Previous work within our laboratory has shown that
NBV generally displays a broad species tropism, and is
capable of infecting various mammalian cell types derived
from diverse mammalian taxa, including human, mouse,
monkey (Vero) and its presumed reservoir host, the
Australian black flying fox (Pteropus alecto) [12]. Within
almost all of these cell lines, NBV - like other fusogenic
orthoreoviruses – causes extensive cell-cell fusion (syn-
cytia) and viral replication. One exception was a mouse
fibroblast cell line, known as L929, which was significantly
less permissive to infection compared to other mamma-
lian cell lines [12]. In NBV infected L929 cells, there was
reduced syncytia and a difference in viral replication com-
pared to permissive cell types, including other mouse cell
types. The ability of L929 cells to resist infection with
NBV was an interesting observation, given that L929 is
also the cell type of choice that is used to propagate the
non-fusogenic mammalian orthoreovirus (MRV) [13].
The L929 cells are also highly permissive to other
fusogenic orthoreoviruses such as Miyazaki-Bali/2007
(MB) [9], Pulau and Melaka [12]. In particular, MB in-
duces large syncytia in L929 and Vero cells as early as
12 h post infection (hpi) [9], and MB replicates to simi-
lar titres in L929 and Vero cells. Taken together, these
findings suggest that the reduced permissiveness of L929
cells to NBV is due to a unique host/pathogen inter-
action between the L929 cell type and NBV. Presently
the molecular mechanisms that underpin this interaction
is unknown. We propose that elucidating the host
factors that regulate the interaction between L929 cells
and NBV will shed light on the elements required for an
effective antiviral response against fusogenic orthoreo-
viruses, thereby informing future therapeutic design.
Fusogenic orthoreoviruses induce cell-cell fusion through
their fusion protein, which is also known as fusion associ-
ated small transmembrane (FAST) proteins [14]. These are
the smallest known viral fusion proteins [15] with molecu-
lar weights ranging from 10 to 15 kDa [16, 17]. Unlike
other fusion proteins these are not involved in virus entry
or exit. The induction of syncytia is not required for virus
entry and is only observed during infection with the FAST
protein trafficked to the plasma membrane, mediating
fusion with neighbouring cells [18]. These fusion proteins
provide an efficient way for dissemination of the virus via
cell to cell spread. The fusion of uninfected cells, allow for
the use of their translational machinery for virus replica-
tion. In addition, syncytia formation serves to sequester the
virus allowing it to avoid immune system components that
attempt to clear infection, such as complement proteins,
antibodies and phagocytes [19, 20].
The generation of monoreassortant fusogenic othoreo-
viruses, obtained through reverse genetics, have been
used to define the role of specific viral proteins, includ-
ing the fusion protein, in L929 cells. Indeed, no differ-
ence in replication kinetics was observed when the S1
segment of MB was replaced with the S1 segment of
NBV [9]. The recombinant monoreassortant MB virus
demonstrated similar replication kinetics compared to
the wild-type MB in L929 cells, thereby indicating that
the NBV S1 segment, which includes the p10 fusion pro-
tein along with the attachment protein σC - is function-
ally maintained in L929 cells. This led us to hypothesise
that host factors rather than viral proteins, are likely to
play a role in determining the permissiveness of L929
cells to NBV.
The molecular events underlying NBV mediated cell--
cell fusion and subsequent viral replication are not fully
understood. The mechanisms by which L929 cells limit
syncytia formation and viral replication is of particular
interest in the broader context of understanding, and
ultimately mitigating, infection with fusogenic non-
enveloped viruses. To this end, the present study aimed
to identify host factors that influence NBV replication
and cytopathic effects by exploiting differences in NBV
permissiveness between cell types. Immortalised bat kid-
ney cells, PaKiT03, which represent a highly permissive
(and natural host) cell type was compared with the rela-
tively resistant L929 cells. To identify critical host fac-
tors, we used an integrated Proteomics Informed by
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Transcriptomics (PIT) approach [21] to simultaneously
quantify changes in gene expression and protein synthesis
at a genome wide scale. Based on transcriptome sequen-
cing (RNASeq) and stable isotope labelling with amino
acids in cell culture (SILAC) coupled with mass spectrom-
etry (MS), this approach has been used to successfully
examine virus host interactions previously in a non-model
species (Fig. 1) [22]. More recently the PIT approach was
evaluated for proteomic characterisation of an organism’s
repertoire of genetic transposable elements [23].
Combining different ‘omic methodologies to answer
biological questions is necessary to provide different
layers of information [24]. For instance, genomics pro-
vides information on the number of genes and sequence
information of these genes, and using these sequences it
is possible to construct phylogenetic trees to compare
evolutionary relationships. The application of transcrip-
tome technologies is for the study of an organism’s tran-
scriptome to assess gene expression activities. Although,
transcript information is obtained it fails to provide
complete information on protein synthesis and their
abundance, which is known to not have a perfect correl-
ation to gene expression through transcription. This is
particularly true for proteins that have functional (en-
zymes) other than a structural role in any biological
system. Although an integrated PIT approach does not
guarantee complete correlation between gene expression
and protein synthesis which is due to the temporal lag in
the sequence of events. It is considered the most repre-
sentative approach in comparison with transcriptomics
and proteomics applied alone.
Methods
Maintenance and SILAC adaption of L929 and PaKiT03
cell types
Immortalised Pteropus alecto kidney cells [25] and L929
cells which were not used in SILAC experiments were
maintained as follows: PaKiT03 cells were grown in
DMEM Nutrient Mixture F-12 Ham with 15 mM
HEPES pH 7.4 (Sigma) and L929 cells were grown in
MEM with 10 mM HEPES pH 7.4 and 2 mM L-
glutamine (Life Technologies) both supplemented with
10% v/v foetal calf serum (FCS).
For SILAC adaption, PaKiT03 and L929 cell types
were maintained in Minimal Essential Media (MEM,
Thermo Scientific) deficient in L-Lys and L-Arg, supple-
mented with 10% (v/v) dialysed FCS and differing com-
binations of L-Lys and L-Arg containing stable isotopes
of carbon and nitrogen. L-Lys-2HCl + L-Arg-HCl
(unlabelled, designated ‘Light’), 13C6 L-Lys-2HCl +
13C6
L-Arg-HCl (‘Medium’) and 13C6
15N2 L-Lys-2HCl +
13C6
Fig. 1 Proteomics Informed by Transcriptomics workflow. (i) Cells are adapted to SILAC media containing Lysine and Arginine with isotopes of
Carbon and Nitrogen. Cells were infected with NBV for 0 (control), 8 and 24 h using an MOI of 1.5. (ii) Total RNA was isolated and mRNA sequenced,
using 100 base pair paired-end reads. (iii) Reads obtained from sequencing, were quality trimmed and transcripts assembled de novo using Trinity.
Assembled transcripts were annotated using BLASTx against the non-redundant UniProtKB/SwissProt protein database. (iv) Sequence reads are
mapped back to the de novo assembled transcriptome using Bowtie2. (v) Differential gene expression testing was calculated with expression values
relative to 0 h control determined by DESeq. (vi) The de novo transcriptome was translated in 6 frames as a database for MS. (vii) Extracted proteins
were separated by SDS-PAGE and digested via in-gel trypsin digestion. (viii) Peptides were analysed by LC-MS/MS and the (ix) MS spectra searched
against the 6-frame translated de novo transcriptome. (x) Peptides are compiled into proteinGroups and the differential expression is calculated
using MaxQuant
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15 N4 L-Arg-HCl (‘Heavy’). Cells were passaged for five dou-
blings, splitting at 1:10 into T25 (25cm2) flasks.
Verification of correct incorporation of isotope labelled
amino acids in cell proteins
Cells from isotope labelled cultures were tested for cor-
rect incorporation of isotopic labelled amino acids into
proteins. Equal quantity of ‘Light’, ‘Medium’ and ‘Heavy’
cell lysates were analysed by SDS-PAGE in MOPS buffer
(Life Technologies) and two randomly selected regions
were excised from the gel for in-gel trypsin digestion
and MS analysis.
Infection of adapted cells with NBV
SILAC adapted L929 and PaKiT03 cells were seeded at
5 × 106 cells into T25 flasks (in triplicate) containing
SILAC medium with appropriate isotope labelled amino
acids and supplemented with 10% (v/v) FCS. Following the
overnight incubation at 37 °C the medium was removed
and cells were washed with sterile PBS. Both cell cultures
were infected with NBV at a MOI of 1.5 for 1 h at 37 °C
with gentle rocking every 15 min. The inoculum was re-
moved and cells were washed with PBS. The inoculum was
replaced with 4 ml of SILAC isotope labelled media. To
confirm infection, SILAC adapted cells were also seeded
into glass coverslips in 24 well plates at a density of 30,000
cells/well and infected with NBV as described above. At 0,
8 and 24 hpi cells were fixed in 4% paraformaldehyde and
immunofluorescence detecting NBV sigma (σ) proteins
were performed with the antiserum for NBV σ2 and σNS
proteins as described previously [12]. In each cell line, the
viral infection was quantified as the number of nuclei per
syncytium, as previously described [12]. The average
number of nuclei per syncytium was calculated using a
minimum of two replicates and statistical significance
tested using a Student’s t-test.
Sampling of NBV infected L929 and PaKiT03 cells
At the sampling time points of 0, 8 and 24 hpi with
NBV, the medium was poured off and cell monolayers
washed with PBS. Cells were then trypsinised and har-
vested after inhibiting trypsin with medium containing
10% v/v FCS. Cells pelleted by centrifugation at 1500 x g
for 5 min were resuspended in 500 μl of PBS. An aliquot
of 100 μl was pelleted by centrifugation as above and
lysed in 350 μl of Buffer RLT (Qiagen) for RNA extrac-
tion and Real-Time PCR. The pellet of 400 μl aliquot was
lysed in SDS-PAGE sample buffer (Life Technologies) for
electrophoretic analysis.
Extraction of RNA for RNA sequencing
All cell lysates in Buffer RLT were homogenised with a
QIAShredder and subjected to RNA extraction. The ex-
traction was completed with the Qiagen RNeasy Mini
Kit with RNA eluted in 30 μl of nuclease free water
(Promega). The concentration of each preparation was
determined by NanoDrop (Thermo Scientific) and Qubit
RNA quantitation. The RNA integrity was determined
following separation on a 0.9% agarose gel 40 mM Tris,
20 mM acetic acid, 1 mM EDTA pH 8.0. An aliquot of
1-3 μg of total RNA (stored on dry ice) was sequenced
on Illumina HiSeq 2000 (100 bp paired end reads) at the
Australian Genome Research Facility (AGRF, Parkville,
Australia).
Sample preparation for SILAC analysis
For SILAC analysis of infected cells, equal quantities of
cell lysates of the ‘Light’, ‘Medium’ and ‘Heavy’ labelled
PaKiT03 and L929 were pooled and separated by 4-12%
SDS-PAGE in MES buffer (Life Technologies). The sam-
ples were stained with Coomassie blue and de-stained
overnight. Pooled lanes for PaKiT03 and L929 SILAC-
labelled cell lysates were excised into 10 (Replicate 1)
and 15 (Replicate 2) equal portions. The proteins within
each gel piece were then subjected to in-gel trypsin di-
gestion for MS analysis as described previously [26].
Peptides were analysed by MS on a LTQ Orbitrap Elite
(Replicate 1, Thermo Scientific) and LTQ Orbitrap Velos
(Replicate 2, Thermo Scientific). Both machines were
equipped with a nanoESI interface with an Ultimate
3000 RSLC nano-HPLC (Dionex Ultimate 3000) and
tandem Dinoex-C18 columns (Acclaim Pepmap nano-
trap (100 Å, 75 μm × 2 cm and Acclaim Pepmap RSLC
100 Å, 75 μm × 15 cm). With the LTQ Orbitrap Elite,
the peptides were separated on to the nano-trap column
with 0.1% (v/v) formic acid in 3% (v/v) CH3CN (5 μl/
min for 5 min) before the enrichment column was
switched in-line. For elution with 0.1% (v/v) formic acid
(solvent A) and 0.l % (v/v) formic acid in 100% (v/v)
CH3CN (solvent B). The flow gradient was: (i) 0-5 min
at 3% B, (ii) 5-6 min, 3-6% B (iii) 6-18 min, 6-10% B (iv)
18-38 min, 10-30% B (v) 38-40 min, 30-45% B (vi)
40-42 min 45-80% B (vii) 42-45 min at 80% B (vii) 45-
46 min, 80-3% B and (viii) 46-53 min at 3% B. The LTQ
Orbitrap Elite was operated in the data-dependent mode
with nanoESI spray voltage of 2.0 kV, capillary
temperature of 250 °C and S-lens RF value of 55%. All
spectra were acquired in positive mode with full scan
MS spectra scanning from m/z 300-1650 in the FT
mode at 240,000 resolution after accumulating to a tar-
get value of 1.0e6. Lock mass of 445.120025 was used.
The top 20 most intense precursors were subjected to
collision induced dissociation (CID) with normalised
collision energy of 30 and activation q of 0.25. Dynamic
exclusion of 45 s was applied for repeated precursors.
The protocol used for peptide analysis on the LTQ
Orbitrap Velos has been described previously [21].
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De novo assembly of RNASeq transcriptome and
differential gene analysis
RNAseq transcriptome 100 bp paired end sequencing
was performed in triplicate (three biological repli-
cates) at 0, 8 and 24 hpi, for both PaKiT03 and L929
cells. FASTQ reads were first groomed using FASTQ
Groomer (v. 1.0.4) [27] to evaluate reads quality, re-
ject low quality reads and ensure correct formatting
for down-stream processing. The total number of
post-filtered reads for each replicate/sample are pre-
sented in Additional file 1: Table S1. Transcripts for
PaKiT03 and L929 samples were assembled de novo
using all sequence reads (i.e. 0, 8 and 24 hpi samples)
in Trinity [28]. To annotate the assembled transcrip-
tomes, a BLASTx searched against the non-redundant
UniProtKB/SwissProt protein database was performed
for each transcript. Only transcripts with a BLASTx
e-value ≤1.0−5 were annotated with gene names. To
perform differential gene expression analysis the
paired groomed FASTQ read files were mapped to
the de novo assembled transcriptome with Bowtie2 (v.
0.2) [29]. A summary of mapping statistics is provided
as Additional file 1: Table S1. The number of reads
mapping to each transcript was quantified using
SAMtools [30] for each sample/replicate. Differentially
expression testing was performed using the R package
DESeq [31]. Only transcripts with an adjusted p-value
≤0.05 and a fold change ≥2 up- or down-regulated
were considered statistically significant. Sequenced
reads from L929 and PaKiT03 samples were also
mapped back to the reference NBV genome with
Bowtie2 (v. 0.2) [29]. Differential expression was not
performed on these samples.
Quantitative analysis of SILAC mass spectra with
MaxQuant
To quantify protein changes following NBV infection in
PaKiT03 and L929 cells mass spectra files from the LTQ
Orbitrap Velos and LTQ Orbitrap Elite were loaded
into MaxQuant (v. 1.4.1.2), with the following group
specific parameters: ‘type: standard – 3 labels, ‘Light’ -,
‘Medium’ – Lys 6 and Arg 6, ‘Heavy’ – “Lys 8 and Arg 10
and requantify – ticked”. In global parameters the
FASTA files used were all frames translation of the de novo
assembled transcriptome as previously described [22]. A
decoy database entailing a reversed transcriptome was also
translated in all frames.
Individual proteinGroup files, containing information
on the MaxQuant identified proteins, were obtained
from each replicate (n = 2) for PaKiT03 and L929 sam-
ples. ProteinGroups identified in both replicates (thus
two or more peptides) were extracted along with the
corresponding abundance ratios at 8 (Medium/Light)
and 24 (Heavy/Light) hpi. The proteinGroup lists were
then filtered to remove common contaminants (keratin)
and those derived from the decoy database. Using
BLASTx information for each transcript, the pro-
teinGroups that contained ambiguous protein ID’s were
removed. The average ratio was calculated from the two
replicates for each protein. Proteins were assessed as
differentially regulated if the fold change was ≥2 in
any direction. Mass spectra files were also searched
against the all frame translation of NBV nucleotide
sequences and using the same parameters as above in
MaxQuant [4].
Pathway analysis
Following BLASTx analysis, the PaKiT03 and L929
transcripts were annotated with UniprotKB/Swiss-Prot
entry names. The official gene symbols were obtained by
converting these entry names to the official gene symbol
with the Database to Database conversion from the bio-
logical DataBase network [32]. Lists of differentially
expressed genes were compiled for each cell line at 8
and 24 hpi. Using the official gene symbol, transcript
redundancy was removed for each list (i.e. duplicate
transcripts removed). Gene sets were then analysed
using the Reactome database [33, 34] to identify over-
represented pathways. For both PaKiT03 and L929 cells
the human database was used. The false discovery rate
(FDR) is presented for each enriched pathway.
Real-time quantitative PCR
Purified RNA was converted into First-Strand cDNA
using SuperScript II Reverse Transcriptase (Life Tech-
nologies) according to manufacturer instructions. The
cDNA was then analysed by the SYBR Green Real-Time
PCR (Life Technologies). Primer design was completed
using Primer3 with the following conditions: “Primer
size – 20 bp, Primer melting point - 60°C, Primer G-C
content – 55 % and Product size – 100 bp minimum,
150 bp optimum, 200 bp maximum”. The final PCR re-
action volume was 20 μl with forward and reverse
primer concentrations at 10 μM (Additional file 1:
Table S1). The templates used were either mouse, bat
or NBV cDNA. The cycle conditions were: “Holding
stage - 50°C for 2 min and 95°C for 2 min; Cycling
stage - 95°C for 15 sec and 60°C for 1 min for 40 cycles
and a melt curve stage of 95° for 15 sec, 60°C for 1 min
and 95°C for 15 sec” on an ABSciex StepOne 7500 Plus
Real-Time PCR System.
The real-time PCR threshold cycle (Ct) data were
exported into an Excel spreadsheet and the Ct value dif-
ferences between samples were calculated with the rela-
tive expression software tool (REST) [35] where the
expression levels of target genes were normalised against
a reference gene, Gapdh.
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Stimulation of PaKiT03 cells with universal type I IFN
PaKiT03 cells were seeded at a density of 3 × 104 cells in
96 well microplates and left overnight at 37 °C to adhere.
The cells were stimulated (in triplicate) with 5000 units of
Universal Type I IFN (UIFN, PBL Assay Science) in
100 μl of serum free medium, DMEM Nutrient Mixture
F-12 Ham with 15 mM HEPES pH 7.4 (Sigma) for 3 h.
Control cells were mock stimulated with serum free
medium only for 3 h. Following the 3 h stimulations
media were removed and both UIFN treated and controls
cells were infected NBV at a MOI of 10 for 1 h. The
cells in the microplate were washed with sterile PBS
and supplied with fresh DMEM Nutrient Mixture F-
12 Ham, 15 mM HEPES pH 7.4, with 2% FCS. At 24
and 40 hpi the entire 96 well microplate was frozen
at −80 °C for virus titration as previously described
[12]. UIFN stimulated and control PaKiT03 cells were
also prepared in 24 well microplates for immuno-
fluorescence microscopy as described previously [12].
Earlier time points were not tested as they had previ-
ously been shown to be negative for viral proteins.
The average number of nuclei per syncytium was
calculated using a minimum of two images and differ-
ences calculated using the Student’s t-test.
Ifnar1 knockdown in L929 cells
The knockdown of the type I IFN receptor, Ifnar1, in L929
cells was performed using siRNAs targeted to Ifnar1
(siGENOME SMARTpool Mouse Ifnar1, 15,975, Dharma-
con). The L929 cells were seeded at a density of 3 × 104
cells per well in a 96 well microplate in duplicate and left
overnight at 37 °C to adhere. L929 cells were transfected
for 48 h with 60 nmol of siRNA Ifnar1 (Dharmafect, Dhar-
macon). To quantify the level of mRNA knockdown, fol-
lowing transfection the supernatants were discarded and
cells lysed with 200 μl of Buffer RLT. RNA was extracted
and gene expression of Ifnar1 following transfection with
siIFNAR1 was assessed with qPCR and differences calcu-
lated using the Student’s t-test.
To assess the effect of Ifnar1 knockdown on NBV rep-
lication the L929 cells were seeded and transfected for
48 h as previously described. Following transfection, the
supernatants were discarded and the cells infected with
NBV at a MOI of 10 with inoculum removed after 1 h.
At 24 and 40 hpi the microplates were frozen at −80 °C
for virus titration. Virus titration was performed in Vero
cells as previously described [12]. In parallel, knockdown
(siIFNAR1+) and non-specific control siRNA knock-
down L929 cells in 24 well microplates were prepared
for immunofluorescence microscopy, for the detection
of NBV σ proteins as described previously [12]. Earlier
time points were not tested as it has previously been
shown that at these time points, viral proteins were not
detectable. The average number of nuclei per syncytium
was calculated from a minimum of two images using the
Student’s t-test.
Results
L929 cells are less susceptible to NBV infection
L929 and PaKiT03 cells were adapted to SILAC medium
containing amino acids, L-Arg and L-Lys labelled with
different isotopes of carbon and nitrogen. The incorpor-
ation of 13C6 L-Lys-2HCl +
13C6 L-Arg-HCl (‘Medium’)
and 13C6
15N2 L-Lys-2HCl +
13C6
15 N4 L-Arg-HCl
(‘Heavy’) was confirmed by MS before virus infection.
Compared to the ‘Light’ cells (12C6,
14N7) peptides
derived from the ‘Medium’ and ‘Heavy’ adapted cells
showed the expected mass-to-charge (m/z) shift of 6
and 8 Da for lysine fragments, respectively, and 6 and
10 Da shift for arginine fragments, respectively
(Additional file 2: Figure S1).
The SILAC adapted cells were infected with NBV
and infection confirmed by immunofluorescence mi-
croscopy. At 24 hpi there was large syncytial events
formed in the PaKiT03 cultures encompassing numer-
ous cell nuclei, while in the infected L929 cultures
only a few cells were infected and the syncytial events
were not as pronounced (Fig. 2a). The infection of
SILAC adapted cell types was consistent with previ-
ously reported differences in infection kinetics for
non-adapted cell types [12]. The number of nuclei
per syncytium was quantified in both cell types and
was significantly higher in the PaKiT03 cells
compared to the L929 cells at 24 hpi (Fig. 2b). The
number of NBV peptides (proteome analysis, Fig. 2c)
and NBV sequence reads (transcriptome analysis, Fig.
2d) were also significantly higher in the PaKiT03 cells
compared to the L929 cells at 24 hpi. At 8 hpi no
major syncytial events were observed in either cell
line. A small number of single infected cells were
observed in PaKiT03 cells at 8 hpi (data not shown).
In line with this finding, we also observed very few
NBV sequence reads or peptides at 8 hpi in either
cell line (data not shown).
Transcripts and proteins are differentially regulated in
response to NBV infection
Differentially regulated genes
A summary of the number of RNAseq reads obtained
for each sample/replicate is provided as Additional file 3:
Table S2. From these paired end reads, 368,115 tran-
scripts for PaKiT03 and 222,549 transcripts for L929
were assembled de novo. The de novo assembled tran-
scriptomes underwent a BLASTx (≤ e-value 1.0−5
threshold) search against the UniprotKB/Swiss-Prot
database to identify and annotate transcripts based on
sequence homology. To assess transcript differential ex-
pression, RNAseq reads from 0, 8 and 24 hpi were
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mapped back to their respective transcriptomes and dif-
ferential expression testing was performed using DESeq
relative to 0 hpi (control).
The broad transcriptome response varied between the
PaKiT03 and L929 cells. PaKiT03 cells demonstrated a
robust up-regulation of transcripts at 8 hpi, and then
less at 24 hpi. In contrast, L929 cells up-regulated more
transcripts at 24 hpi compared to 8 hpi (Fig. 3a). Fur-
thermore, both cell types up-regulated unique sets of
transcripts at 8 and 24 hpi, with only moderate overlap
between these time-points. Both cell types had more
transcripts down-regulated at 24 hpi compared to 8 hpi.
As expected significant redundancy was observed in the
sets of differentially expressed transcripts. That is,
multiple transcripts for many genes were up- or down-
regulated. Based on the BLAST annotation for each
transcript, we collapsed the list of differentially
expressed transcripts into lists of differentially expressed
genes (Fig. 3a). Lists and expression statistics for signifi-
cantly differentially expressed transcripts from PaKiT03
and L929 cells are provided as Additional file 4: Table S3
and Additional file 5: Table S4 respectively.
A subset of differentially expressed genes detected by
RNASeq were examined by qPCR to determine the
validity of the analysis. The genes investigated were,
Cxcl10, Cxcl11, Ifit1 and Ifit3. In both cell types, the
c
a
d
b
Fig. 2 NBV infection of SILAC adapted PaKiT03 and L929 cells at MOI 1.5. a Syncytia observed in PaKiT03 cells are progressively larger while
significantly smaller syncytia occur in L929 cells. Visualised by immunofluorescence microscopy (DAPI in blue and NBV σ proteins in green). b There is a
higher average number of nuclei per syncytium in PaKiT03 cells compared to L929 cells. c The number of NBV peptides identified between PaKiT03
and L929 cells at 24 hpi indicates more NBV peptides present in PaKiT03 cells (green) compared to L929 cells (yellow). d The number of NBV mapped
reads shows more reads for every NBV segment in the infection of PaKiT03 cells (green) compared to L929 cells (yellow). ***p < 0.001
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analysis of gene expression by qPCR generally showed
expression profile similar to those determined by RNA-
Seq, However, most of the fold changes determined by
qPCR were lower compared to those from the RNASeq
analysis (Additional file 6: Figure S2).
Differentially regulated proteins
Mass spectra obtained for two biological replicates were
searched against the translated de novo assembled tran-
scriptomes for each cell type. Following strict filtering
(see methods), a total of 2072 and 2554 unambiguous
proteins were identified in the PaKiT03 and L929 cells,
respectively. Only proteins with an average ≥ 2-fold
change (up or down) at 8 and/or 24 hpi compared to 0
hpi were deemed significantly differentially expressed.
Compared to the number of transcripts/genes differen-
tially expressed, far fewer proteins were differentially
expressed in either cell type at 8 and/or 24 hpi. In both
cell types, more proteins were up- and down-regulated
at 24 hpi compared to 8 hpi. In most cases the proteins
up-regulated at 8 hpi were also up-regulated at 24 hpi
(Fig. 3b). The proteinGroups files from MaxQuant for
PaKiT03 and L929 cells are provided as Additional file
7: Table S5 and Additional file 8: Table S6, respectively.
Host protein up-regulation is associated with increased
transcript expression
By virtue of the PIT approach we were able to examine
the relationship between gene and protein expression in
response to NBV infection. For this analysis, we calcu-
lated the average mRNA fold change for all transcripts
that were assigned to differentially expressed proteins.
The proteins were annotated based on their transcript
annotation (determined through BLASTx as described
above). Given only a small number of proteins were dif-
ferentially expressed at 8 hpi, we restricted this analysis
to only those proteins that were differentially expressed
at 24 hpi. In general, we found a positive relationship
between protein up-regulation and mRNA up-regulation
in both cell types (Fig. 4a and b). That is, most proteins
up-regulated were also up-regulated at the mRNA level.
Furthermore, many of the proteins up-regulated in L929
cells at 24 hpi were also up-regulated in the PaKiT03
cells (Fig. 4a and b). In contrast, and in both cell types,
proteins down-regulated at 24 hpi were generally not
down-regulated at the mRNA level. Taken together these
findings suggest that increased protein expression within
the host is likely regulated through mRNA transcrip-
tional activity in response to NBV. In contrast, the
processes leading to the down-regulation of host pro-
teins following NBV infection are likely driven at the
post-transcriptional level.
Pathway analysis
To identify the major biological processes differentially
regulated in response to NBV infection, we performed
pathway analysis using the Reactome database [33, 34].
Fig. 3 Assessment of differential regulation of transcripts and proteins.
a Genes and transcripts up- and down-regulated at 8 and 24 hpi with
NBV. Transcripts were deemed significantly differentially expressed if
their q-value (adjusted p-value) < 0.05 and had ≥2-fold change (up or
down). Values shown in parenthesis represent the number of differentially
expressed transcripts (including redundancy), whereas values shown
above represent the number of differentially expressed genes (transcript
redundancy removed). b Proteins were assessed as differentially regulated
if they had a ≥ 2-fold change (up or down) relative to 0 hpi. The value in
parenthesis indicates the total number of proteins differentially
expressed, while the value above signifies the number of
non-redundant proteins differentially expressed
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Given only a moderate number of proteins were up-
regulated – and the fact that the majority of those
proteins were also up-regulated at the mRNA level – we
restricted this analysis to only the gene expression data
set. In both the L929 and PaKiT03 cells, overrepresented
pathways were identified in the up-regulated gene sets at
8 and 24 hpi. A full description of enriched pathways for
L929 and PaKiT03 cells are included as Additional file 9:
Table S7 and Additional file 10: Table S8. In both cell
types, the broad ‘Immune Response’ (R-HAS-168256)
pathway, including its sub-pathways ‘Adaptive Immune
Response’, ‘Cytokine Signalling’ and ‘Innate Immune
Response’ were the most significantly overrepresented
pathway at both 8 and 24 hpi (Fig. 5). Within these sub-
pathways, RIG-I/MDA5 mediated induction of inter-
feron, interferon signalling and MHC class I antigen
processing/presentation were the most significantly
overrepresented pathways in both cell types (Fig. 5).
In contrast to the pathways identified in the up-
regulated gene sets, we observed significantly less en-
richment for pathways in the down-regulated gene sets.
One exception of particular relevance to NBV was the
down-regulation of pathways related to cell-cell junction
organisation in the PaKiT03, but not L929 cells. Indeed,
the claudin and cadherin genes (CDH6, CLDN4, CLDN3,
CLDN19), which play important roles in cell-cell
adherence, were down-regulated in the PaKiT03 cells.
This disruption of cell-cell organisation molecules may
be a direct consequence of the extensive cell-fusion and
syncytia formation induced by NBV.
Immune response
As described above immune response pathways, and in
particular IFN signalling, were significantly overrepre-
sented in both cell types. Subtle differences however
existed in the composition of genes and their expres-
sion kinetics. Central to the immune response pathways
described above is the up-regulation of the intracellular
pathogen recognition receptors (namely the RIG-I-like
receptors) RIG-I (DDX58) and MDA5 (IFIH1) and
subsequent downstream production of IFN molecules.
In both cell types DDX58/Ddx58 and IFIH1/Ifih1 were
up-regulated at the mRNA and protein level (Fig. 6a
and b). Consequently, we also observed an mRNA up--
regulation of the transcription factors that are respon-
sible for relaying RIG-I/MDA5 signals to promote the
transcription of IFN genes. These genes included IFN
regulatory factors (IRFs) and NF-κB genes. In both
L929 and PaKiT03 cells, IFNB1/Ifnb1 was up-regulated
significantly at the mRNA level at both 8 and 24 hpi. In
L929 cells, we also observed an up-regulation of Ifna2
and Ifna5.
a b
Fig. 4 Comparison of transcripts versus proteins fold changes. Comparison of transcript versus protein expression. The relationship between
transcript and protein expression was investigated for all proteins up- or down-regulated at 24 hpi in (a) PaKiT03 and (b) L929 cells. For proteins
that had multiple transcripts, the average log2 fold-change was calculated for all transcripts belonging to that protein. Both protein and transcript
expression is presented as a log2 fold-change (relative to 0 hpi). Vertical dashed lines represent the 2-fold (1 fold log2) threshold for proteins
deemed as up- (red points) and down-regulated (green points)
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In line with the up-regulation of type I IFN’s, we
also observed a significant induction of IFN stimu-
lated genes (ISGs) at both the mRNA and protein
level. This included the IFN-induced proteins with
tetratricopeptide repeats (IFIT1/Ifit1, IFIT2/Ifit2 and
IFIT3/Ifit3), Myxovirus (Influenza virus) resistance
genes (MX1/Mx1 and MX2/Mx2) and 2-5A synthetase
family members (OAS1, OAS2/Oas2, OAS3/Oas3 and
OASl) (Fig. 6a and b). Interestingly the kinetics of this
response varied between the cell types. Indeed,
PaKiT03 cells appeared to show a stronger ISG re-
sponse at 8 hpi compared to L929 cells for some
genes such as the IFN-induced transmembrane pro-
teins (IFITM1 and IFITM2/Ifitm2) and MX1/Mx1.
The up-regulation of IFNB1/Ifnb1 was also much
stronger within the PaKiT03 cells at 8 hpi compared
to L929 cells. We also observed a difference in pro-
tein expression between the two cell types. There
were 34 and 42 genes in L929 and PaKiT03 cells re-
spectively that were associated with type I IFN signal-
ing. However, there was protein evidence for 14 genes
in the L929 cells and 5 genes in the PaKiT03 cells.
Genes and proteins related to MHC class I antigen
presentation were also significantly up-regulated in
both cell types, suggesting activation of cell mediated
immune responses.
Decreasing IFN signalling increases NBV replication in
L929 cells
Given the significant up-regulation of type I IFN signal-
ling pathways in L929 and PaKiT03 cells, we then exam-
ined the functional effect of IFN signalling on NBV
replication and viral mediated fusion. Type I IFN signal-
ling is initiated through the binding of type I IFNs to the
type I IFN α/β receptor which is composed of two pro-
teins, IFNAR1/Ifnar1 and IFNAR2/Ifnar2 [36]. We pos-
tulated that the strong IFN signalling response in L929
cells may be associated with the reduced viral titre ob-
served in these cells. To investigate this supposition, we
first used siRNAs targeted to Ifnar1 transcript (siIF-
NAR1) to knockdown the type I IFN signalling pathway.
Due to the paucity of bat specific reagents, we could not
undertake siRNA experiments within the PaKiT03 cells.
The efficiency of the knockdown was quantified by
qPCR and it was confirmed that after 48 h transfection
with siIFNAR1 there was a significant (p-value ≤0.001)
decrease (approximately 70%) in gene expression of
Ifnar1 in comparison to cells transfected with non-
specific siRNA (Fig. 7a). The effects of Ifnar1 knock-
down on viral replication and cytopathic effects was
assessed at 24 and 40 hpi. These time points were
chosen because they represent the earliest time point
when viral induced cell fusion is seen in L929 cells (24
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Fig. 5 Reactome pathway analysis of up-regulated genes. The most significantly overrepresented immune pathways from L929 and PaKiT03 cells are
illustrated with their corresponding FDR values. The broad Immune Response pathway is subdivided into the lower level pathways Cytokine Signaling,
Innate Response and Adaptive Response, which are further divided into the sub-pathways shown. Grey tiles indicate where no enrichment was observed.
The FDR value represents the over-representation probability corrected for false discovery rate and was calculated by Fabregat et al. [34]
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hpi), as well as a later time point when increased viral
replication has been seen previously [12].
The average number of nuclei per syncytium was quanti-
fied following infection of L929 cells treated with siIFNAR1
and with non-specific siRNA. At 24 hpi in siIFNAR1
treated L929 cells there was a lower but not statistically
significant average number of nuclei per syncytium com-
pared to cells treated with the non-specific siRNA. How-
ever, by 40 hpi the L929 cells treated with siIFNAR1 had a
higher average number of nuclei per syncytium compared
to non-specific siRNA treated cells (Fig. 7b).
The progression of syncytia formation during NBV
infection was also evaluated by immunofluorescence
microscopy through the detection of NBV σ proteins in
Ifnar1 knockdown cells. At 24 hpi, cells infected with
virus were fusing with neighbouring cells. By 40 hpi, an
increase in the number of nuclei contributing to syncytia
were observed in the Ifnar1 knockdown cells. In con-
trast, the L929 cells treated with non-specific siRNA
showed no increase in the number or syncytia compared
to the previous time point, 24 hpi (Fig. 7c). The effect of
Ifnar1 knockdown on efficiency of NBV replication in
L929 cells was statistically significant (p ≤ 0.05) with an
increase in virus titre (half a log) at 24 hpi in siIFNAR1
treated cells but not at 40 hpi (Fig. 7d).
Increasing IFN signalling delays NBV replication in
PaKiT03 cells
As inhibition of IFN signalling resulted in an increased
NBV infection, it was hypothesised that enhancing IFN
signalling in PaKiT03 cells would reduce NBV replica-
tion. Thus, the type I IFN signalling pathway was in-
duced in PaKiT03 cells by treatment with UIFN.
Previous studies on P. alecto cells have shown that treat-
ment of UIFN for 3 h induces the expression of IFN
stimulated genes, ISG54 and ISG56, members of the IFN
signalling pathway to at least 5 h post treatment [37].
The progression of virus infection following treatment
with UIFN was also assessed by syncytia formation and
the average number of nuclei per syncytium was quanti-
fied. These observations were confirmed by the intensity
of detectable virus σ proteins at 24 hpi under immuno-
fluorescence microscopy following UIFN treatment. At
24 hpi there was a significant increase in the average
number of nuclei contributing to syncytia in mock cells
compared to treated cells. This was also observed by
immunofluorescence microscopy with a decrease in the
abundance of virus σ proteins in treated cells. However,
by 40 hpi, large syncytia encompassing numerous nuclei
were observed in both treated and mock cells and quan-
titation of the average number of nuclei per syncytium
was similar (Fig. 8a and b).
The increased induction of IFN signalling had an effect
on virus replication in PaKiT03 cells. At 24 hpi in UIFN
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Fig. 6 Visualisation of gene and protein expression values. Expression
values of (a) L929 and (b) PaKiT03 genes and proteins at 8 hpi and 24
hpi that are associated with the MHC class I presentation, RIG-I/MDA5
and type I IFN signalling pathways. Fold change is log2 for gene
expression. Where multiple transcripts were identified only the
most significant (lower adjusted p-value) expression value was used.
Grey tiles indicate where no quantitative value was obtained
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treated cells, the virus titre increased to 101.99 TCID50/ml
but was lower compared to mock cells with a titre of 104.16
TCID50/ml. At 40 hpi the virus titre in both treated and
mock cells was similar with virus titres of 104.24 TCID50/ml
and 104.19 TCID50/ml, respectively, indicating that the
induction of the IFN pathway was declining (Fig. 8c).
Discussion
Bats are now recognised as a major reservoir of import-
ant zoonotic viruses. High profile examples include the
henipaviruses, SARS [38] and MERS [39] coronaviruses,
and the filoviruses, Ebola [40] and Marburg [41]. Bat
borne Pteropine orthoreoviruses have also been associ-
ated with human disease and represents a growing pub-
lic health concern. Despite its isolation almost four
decades ago, little is known concerning the zoonotic po-
tential of NBV. Our previous work has shown that NBV
can infect and replicate in a wide variety of cell lines,
and cause extensive fusogenic cytopathic effects in per-
missive cell lines. The present study, aimed to investigate
the host response further by identifying the molecular
events that underpin NBV infection and syncytia forma-
tion. We proposed that by exploiting two cell types
which differ in their susceptibility to NBV, we may also
be able to identify host factors that influence cell
tropism. Interestingly, despite the fact that the cell lines
differed considerable in their ability to support NBV rep-
lication, the host response of PaKiT03 and L929 cells
was remarkably similar. Immune response processes,
namely IFN production and signalling, were highly up--
regulated at the mRNA and protein level in both cell
types. Indeed, genes and proteins involved in RIG-I/
MDA5 pathogen recognition receptors; IFN production;
and ISG stimulation were induced at either 8 hpi and/or
24 hpi.
While both cell types showed an overall similar
response in respect to immune system process, the ex-
pression kinetics – particularly at the mRNA level – var-
ied between the cell lines. Indeed, PaKiT03 cells
demonstrated a stronger up-regulation of IFNB1 and the
ISGs (MX1, IFITM2 and IFITM3) at 8 hpi compared to
the L929 cells at the same time point. We suspect that
the early (8 hpi) induction of IFNB1 and its downstream
signalling in the PaKiT03 cells may be a consequence of
the increased viral transcription/replication within these
cells compared to L929 cells. In line with previously
published work [42], we observed no induction of IFN-α
in the PaKiT03 cells, while both Ifna2 and Ifna5 were in-
duced in the L929 cells at 24 hpi. This is similar to pre-
vious work from our laboratory that has shown that the
a
d
b c
Fig. 7 Inhibition of IFN signalling in L929 cells using siRNAs targeted to murine Ifnar1 (siIFNAR1). a Expression of Ifnar1 following treatment with
siIFNAR1. b Average number of nuclei per syncytium in siIFNAR treated and non-specific siRNA treated cells infected with NBV at 24 and 40 hpi. c Visualisation
by immunofluorescence microscopy of siIFNAR1 treated and non-specific siRNA treated cells following infection with NBV at MOI 10 at 24 and 40 hpi. (DAPI
in blue and NBV σ proteins in green). Representative pictures are presented here. *p < 0.05, ***p < 0.001, ns = non-significant. d NBV titre following
infection at MOI 10 in siIFNAR1+ and non-specific siRNA L929 cells (error bars showing standard error from the mean, n = 3)
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transcript of IFN-α is constitutively expressed in P.
alecto cells and tissues, but is not inducible following
viral infection in PaKiT03 cells [42]. The fact that
IFNB1 was both more rapidly and strongly induced in
PaKiT03 cells may suggest that this is a way these
cells compensate for a lack of inducible IFN-α. Add-
itional research will be required in the future to ex-
plore this hypothesis.
Infection of cells with virus results in a large induction
of ISGs. Interestingly, ISG15 that has known antiviral ac-
tivity against a number of viruses such as Respiratory
syncytial virus [43], Chikungunya virus [44], Ebola virus
[45] and MRVs [46] was strongly up-regulated in
PaKiT03 and L929 cells at the gene level. This expres-
sion of ISG15 is evident in the L929 cells at a protein
level, however, there was no evidence of protein expres-
sion in the PaKiT03 cells. The antiviral activity of ISG15
is through the conjugation to other proteins, altering its
function, and is termed ISGylation. Given the effect that
ISG15 has on a broad range of viruses, perhaps there is
a similar interaction occurring in L929 cells and not in
PaKiT03 cells with NBV infection. As there is no evi-
dence of ISG15 expression in PaKiT03 cells which ex-
hibits extensive CPE and high virus titre compared to
L929 cells, adds credence to this theory [47].
This is not the first study to show that reoviruses can
induce IFN production and signalling pathways. Indeed,
mammalian reovirus dsRNA has been shown to be
recognised by RIG-I and MDA5 and causes an induction
of the IFN response [48]. Not only that, reoviruses are
also susceptible to the effects of this IFN response [49].
The proteomic response following infection of HEK293
and HeLa cells with mammalian reovirus serotypes Lang
(T1L) and Dearing (T3D) respectively has also been
studied [50–52]. Not surprisingly, an induction of proteins
associated with the immune response (ISG15/IFIT1/
STAT1) was observed. However, the infection of HeLa
cells with T1L and T3D resulted in different proteomic
profiles, with T3D showing a strong induction of proteins
involved in immune regulation compared to T1L. This is
seemingly due to the lethal infection caused by T3D
compared to T1L [53].
In our study, the IFN response was the dominant
biological process up-regulated in both cells types. The
differing level of infection/CPE observed in the two cell
types did not appear to correlate with the IFN response.
That is, PaKiT03 cells demonstrated a strong IFN re-
sponse while significant viral transcription, translation
and replication occurred. In contrast, L929 cells also
showed a strong IFN response, however in the absence
a
c
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Fig. 8 Stimulation of IFN signalling with UIFN in PaKiT03 cells. a Quantitation of the number of nuclei per syncytium in UIFN treated and mock
PaKiT03 cells. b Visualisation by immunofluorescence microscopy of PaKiT03 cells treated with UIFN and mock following NBV infection at 24 and
40 hpi (DAPI in blue and NBV σ proteins in green). Representative pictures are shown here. **p < 0.01, ***p < 0.001, ns = non-significant c NBV
titre at 24 and 40 hpi following 3 h simulation with UIFN of PaKiT03 cells prior to virus infection
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of significant viral infection. Given these finding, it ap-
peared unclear whether the IFN response in either cell
line was effective at reducing NBV replication. To ad-
dress this question, we investigated the functional rele-
vance of IFN signalling on NBV replication in L929 and
PaKiT03 cells. We showed that NBV replication and
CPE was reduced in the PaKiT03 cells (at 24 hpi) when
cells were primed with Universal type I IFN. Moreover,
disruption of the IFN signalling pathway – through
siRNA transfections – increased the replication of NBV
within the L929 cells. Taken together, these experiments
demonstrated that the type I IFN response is indeed
capable of reducing NBV replication in both PaKiT03
and L929 cells. However, given the strong IFN response
seen in the PaKiT03 cells, it seems unlikely that the IFN
activity is solely responsible for inhibiting NBV replica-
tion in the L929 cells. Reduced viral receptor expression,
could also contribute to the increased resistance of L929
cells to NBV. However, to date, no host molecules have
been identified as receptors that are required for NBV
infection in any cell type.
The parallel integration of proteomic and transcrip-
tomic datasets provides multidimensional insights of
host-pathogen interactions. Certainly, within our study
we found that the majority of proteins up-regulated fol-
lowing NBV infection, were also up-regulated at the
mRNA level. However, proteins down-regulated were
generally not down-regulated at the mRNA level. Taken
together these findings suggest that increased protein
expression within the host is likely regulated through
mRNA transcriptional activity in response to NBV. In
line with this theory, we observed the up-regulation of
important host transcription factors that specifically
promote the expression of immune gene sets. Indeed, in
both cell types we observed up-regulation of signal
transducer and activator of transcription (STAT1/Stat1
and STAT2/Stat2) and IFN regulatory factors, IRF [54],
both of which are essential for IFN signalling pathways.
In contrast, the processes leading to the down-
regulation of host proteins following NBV infection may
be driven at the post-transcriptional level, or possibly a
direct consequence of virus mediated degradation. It has
been shown that proteins are able to target cellular
translation factors, as is the case during feline calicivirus
infection, where virus encoded proteases cleave
eukaryotic initiation factor, eIF4G, and inhibits host pro-
tein synthesis [55]. Additionally, it has been shown that
MRV infection, results in the inhibition of host protein
synthesis. This inhibition is a stress response that is initi-
ated by the cell through the recognition of dsRNA with
dsRNA kinase, PKR, resulting in the phosphorylation of
the translation initiation factor, eIF2α [56]. The phos-
phorylation limits the formation of the ternary complex
eIF2/GTP/tRNAimet that binds with the 40S ribosomal
subunit to initiate translation. This in turn results in the
cytoplasmic aggregation of cellular mRNAs and transla-
tion factors termed stress granules [57]. The stress
granules hold mRNAs in a translationally inactive state
until the removal of the stressor and recovery of the cell,
where the mRNA is again translated [58]. Although this
response serves to inhibit virus replication, MRV is able to
escape the halt in protein expression by disrupting the
stress granules [59]. This strategy allows the translation of
viral but not cellular mRNA. In addition, the MRV σ3 pro-
tein can interact directly with PKR, preventing its activation
and subsequent phosphorylation of eIF2α and in this case,
both cellular and viral translation proceeds [59–61].
For a fusogenic virus, one of the hallmarks of NBV in-
fection within permissive cell types is virus mediated
cell-cell fusion, or syncytia. Syncytia formation from
NBV infection is caused by the p10 protein [14]. As a
non-structural protein, p10 is produced during infection
and transported to the cell surface mediating fusion be-
tween neighbouring cells. Within the present study we
detected p10 transcripts and peptides in the PaKiT03
cells, but not L929 cells, at 24 hpi. Interestingly, in line
with the significant cell-cell fusion observed in the
PaKiT03 cells, we observed a down-regulation of genes
involved in cell-cell adherence and junctions. In a
normal healthy cell, claudin and cadherin proteins, act
to maintain tight cell-cell junctions/organisation [62].
The loss of cell-cell junctions and the formation of
multi-nucleated syncytia seen in NBV infected cells, may
be directly related to the down-regulation of these genes.
The importance of cell-cell fusion and syncytia formation
in promoting NBV replication remains unclear. In avian
reovirus replication it has been shown that syncytia
formation is not an essential step but it enhances the virus
induced CPE and the release of virus progeny [63]. We
have also shown previously with a low cell density
infection with NBV, in an environment not favourable for
syncytia formation, replication and syncytia still occurred
but at a reduced rate [12]. It therefore seems plausible that
intervention strategies which aim to inhibit the fusogenic
activity of NBV, through directly targeting p10 or restoring
cell-cell organisation, could reduce NBV replication.
While we have shown that IFN signalling can influence
NBV replication in both cell types, the exact mechanism
still remains to be identified. In addition, the contribut-
ing effect of the type II and III IFN response cannot be
ruled out as they too are known to have antiviral proper-
ties. Elucidation of the IFN mechanism in play will be
challenging as it is incredibly diverse and involves many
different molecules. Another part of the IFN response
that may be playing a role in controlling NBV replication
are the IFN-induced transmembrane proteins (IFITMs).
These proteins are downstream of IFN signalling and are
known to block viral replication and syncytia formation
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by restricting membrane fusion [64]. IFITM2/Ifitm2 and
IFITM3/Ifitm3 were up-regulated in both PaKiT03 and
L929 cells. The effect on syncytia formation of IFITMs
has been demonstrated in HIV infection previously.
Here, transfected cells expressing IFITM proteins signifi-
cantly inhibited HIV spread and syncytia formation by
antagonising the virus envelope protein [65]. Interfer-
ence of membrane fusion affects virus entry and has
been demonstrated against a range of viruses including
Marburg virus, Ebola virus, SARS-CoV and Influenza A
virus [66]. The IFITM proteins have also been shown to
restrict infectivity and replication of reoviruses, the only
known group of non-enveloped viruses to be affected.
Although the exact mechanism of action of IFITMs dur-
ing the replication of reoviruses is unclear, studies on
Ifitm3 proposes that it acts on endosomes that are uti-
lised by the virus during either entry or replication [67].
Conclusions
Utilising the PIT methodology, we investigated and iden-
tified pathways that potentially contribute to the differ-
ence in susceptibility between L929 and PaKiT03 cell
types during NBV infection. The subsequent functional
studies on the IFN signalling pathway demonstrates it
influences NBV replication. In addition, our transcrip-
tomic and proteomic data also identified a number of
downstream mechanisms during infection for further in-
vestigation and may be applicable to NBV and other
fusogenic orthoreoviruses within this species.
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